GlassScriptPhysician profile
Umesh K Gidwani
NPI 1861431744
$6,126.01
in general payments reported to CMS, 2019-2025
17 companies · $1,146 in 2025
The $1,146 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $969 · 2020: $177 · 2021: $2,348 · 2022: $604 · 2023: $347 · 2024: $535 · 2025: $1,146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,229 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,228.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuwellis, INC. | $3,445.22 | 2019-2025 | Aquadex Smartflow Console |
| Becton, Dickinson and Company | $800.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $268.39 | 2019-2024 | Wainua, Andexxa |
| Chiesi USA, INC. | $214.69 | 2019-2021 | |
| Abiomed | $209.82 | 2019 | |
| Medtronic Vascular, INC. | $195.64 | 2019 | |
| Boston Scientific Corporation | $144.90 | 2024 | |
| Kaleo, INC. | $125.00 | 2024 | Auvi-Q |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Glaxosmithkline, LLC. | $125.00 | 2023 | Bexsero |
| E.R. Squibb & Sons, L.L.C. | $110.22 | 2022-2023 | Camzyos |
| Janssen Pharmaceuticals, INC | $97.53 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $90.32 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $75.00 | 2021 | |
| Abbott Laboratories | $48.13 | 2023 | Mitraclip |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $29.95 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Umesh Gidwani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.